Get Your Personalized Supplement StackSupplement Stack Quiz

Saberry

Also known as: Phyllanthus emblica, Amla, Indian gooseberry, Saberry, Emblica officinalis

Overview

Saberry® is a standardized extract derived from the fruit of *Emblica officinalis*, commonly known as Amla or Indian gooseberry. This botanical dietary supplement is rich in potent antioxidants, particularly β-glucogallin, to which many of its beneficial effects are attributed. Traditionally used in Ayurvedic medicine, *E. officinalis* extracts like Saberry® are now being researched for their potential in modern health applications. The primary focus of current research is on its ability to improve cardiovascular health, optimize lipid profiles, and support glycemic control. While some studies are industry-associated, the overall evidence base, including several randomized controlled trials (RCTs) and meta-analyses, suggests moderate to high quality evidence for its efficacy in these areas. Saberry® is typically consumed orally in capsule or tablet form.

Benefits

Saberry® and *Emblica officinalis* extracts offer several evidence-based benefits, primarily in metabolic and cardiovascular health. Meta-analyses of randomized controlled trials (RCTs) consistently show significant improvements in lipid profiles, including reductions in total cholesterol (mean difference ~ -21 mg/dL) and LDL cholesterol (~ -25 mg/dL), alongside increases in beneficial HDL cholesterol (~ +4.7 mg/dL) after 8-12 weeks of supplementation. These effects are supported by multiple independent studies, indicating a moderate to strong level of evidence. For glycemic control, RCTs have demonstrated that Saberry® can significantly decrease fasting blood sugar, postprandial blood sugar, and HbA1c levels, with a 2 g/day dose showing superior glycemic control compared to metformin in one study. This suggests a promising role for Saberry® in managing diabetic dyslipidemia. Furthermore, meta-analyses indicate beneficial effects on blood pressure and inflammatory markers, contributing to overall cardiovascular risk reduction. The potent antioxidant properties of β-glucogallin in Saberry® are believed to underpin these protective effects against oxidative stress.

How it works

Saberry® exerts its therapeutic effects primarily through its active compound, β-glucogallin. This polyphenol acts as a powerful antioxidant, effectively scavenging free radicals and mitigating oxidative stress throughout the body. In terms of lipid metabolism, the extract is thought to modulate cholesterol synthesis and uptake, potentially by inhibiting HMG-CoA reductase (a key enzyme in cholesterol production) and enhancing the activity of LDL receptors, leading to reduced LDL and total cholesterol levels. For glycemic control, Saberry® appears to improve insulin sensitivity and may reduce glucose absorption from the gut. Its anti-inflammatory properties also contribute to its cardiovascular benefits by reducing systemic inflammation. The standardization of Saberry® ensures a consistent concentration of β-glucogallin, supporting its oral bioavailability and consistent therapeutic action.

Side effects

Saberry® and other *Emblica officinalis* extracts are generally well-tolerated, with clinical trials reporting no serious adverse events. Mild gastrointestinal discomfort is a rare side effect that may occur. There are no significant drug interactions or contraindications widely reported in the scientific literature. However, due to a lack of sufficient safety data, Saberry® is not recommended for use during pregnancy. As with any supplement, individuals with pre-existing medical conditions or those taking prescription medications should consult a healthcare professional before starting supplementation. While the safety profile appears favorable based on current research, long-term safety data beyond 12 weeks of continuous use are limited, and ongoing monitoring is advisable.

Dosage

Effective dosages of Saberry® in clinical studies typically range from 500 mg to 2 g per day of the standardized extract (standardized to 10% β-glucogallin). For optimal benefits, particularly in glycemic and lipid control, a higher dose of 2 g per day has shown superior results compared to lower doses and even compared to metformin in one specific randomized controlled trial. Saberry® supplements are usually administered orally, commonly in capsule or tablet form. It is generally recommended to take the supplement with meals to potentially enhance absorption. To observe significant clinical effects, consistent daily intake for at least 8 to 12 weeks is necessary. There are no established upper limits or safety thresholds beyond the studied doses, but adherence to recommended dosages is advised.

FAQs

Is Saberry® safe for long-term use?

Current randomized controlled trials (RCTs) have demonstrated good safety for up to 12 weeks of use. While longer-term data are limited, no major safety concerns have emerged from existing research.

Can Saberry® replace medications like metformin?

Saberry® shows promise as an adjunct or alternative for mild diabetic dyslipidemia. However, it should not replace prescribed medications without strict medical supervision and guidance from a healthcare professional.

When are the effects of Saberry® typically noticeable?

Significant improvements in lipid profiles and glycemic parameters are generally observed after consistent daily supplementation for at least 8 to 12 weeks.

Is Saberry® effective for individuals without diabetes or dyslipidemia?

While the primary evidence supports its use in dyslipidemic and diabetic populations, benefits in healthy individuals are less extensively studied. Its antioxidant properties may offer general health benefits.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC10251691/ – This meta-analysis of randomized controlled trials (RCTs) investigated the effects of *Emblica officinalis* on cardiovascular disease risk factors. It found significant improvements in lipid profiles and blood pressure, utilizing rigorous Cochrane methods to assess the evidence. The study highlights the potential of *E. officinalis* in cardiovascular health management.
https://pdfs.semanticscholar.org/5d5e/b908ffb1c59610071088d8da7badfc3b951b.pdf – This meta-analysis of four RCTs specifically focused on the impact of *Emblica officinalis* on lipid parameters. It reported statistically significant reductions in total cholesterol and LDL cholesterol, along with an increase in HDL cholesterol, after 12 weeks of supplementation. The study provides clear statistical evidence for its lipid-modulating effects.
https://www.binasss.sa.cr/mar23/27.pdf – This systematic review and meta-analysis of six RCTs confirmed the beneficial effects of *Emblica officinalis* on lipid profile improvements and glucose regulation. It included subgroup analyses to explore variations by dose and duration, providing a comprehensive overview of its metabolic benefits, though noting potential publication bias.
https://pubs.rsc.org/en/content/articlehtml/2022/fo/d2fo01862d – This randomized controlled trial compared Saberry® to metformin in patients with diabetic dyslipidemia over 90 days. It found that a 2 g/day dose of Saberry® was superior to metformin 500 mg in improving fasting blood sugar, postprandial blood sugar, and HbA1c, while also being well-tolerated. The study suggests Saberry® as a promising intervention for metabolic control.